This inventor holds 1 USPTO granted patent. Top assignee: University of Cincinnati. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Thomas A. Campbell: Innovator in Neurological Diagnostics
Introduction
Thomas A. Campbell is a notable inventor based in Massillon, OH (US). He has made significant contributions to the field of neurological diagnostics through his innovative research and patent work. His dedication to understanding and diagnosing neurological diseases has led to advancements that can aid in patient care.
Latest Patents
Thomas A. Campbell holds a patent for a method of detecting axonal damage from associated disease states using tau monoclonal antibodies. This patent addresses the elevated levels of axonally-derived proteins, such as tau and neurofilament proteins, found in the cerebrospinal fluid (CSF) and brain tissue of patients with various neurological diseases. The development of three monoclonal antibodies (MAbs) that recognize CSF tau proteins has been a key aspect of his work. These MAbs label a range of tau proteins in CSF from patients suffering from conditions that produce axonal damage, such as head trauma or CNS tumors, while showing no labeling in CSF from healthy controls. The high levels of tau protein in CSF have been identified as diagnostic indicators of axonal degeneration in cases of head trauma. To further assist in diagnosis, an ELISA assay was developed using these MAbs.
Career Highlights
Thomas A. Campbell is affiliated with the University of Cincinnati, where he continues to contribute to research in the field of neurology. His work has been instrumental in advancing the understanding of axonal damage and its implications for various neurological conditions.
Collaborations
One of his notable collaborators is Frank P. Zemlan, with whom he has worked closely on research related to neurological diagnostics.
Conclusion
Thomas A. Campbell's innovative work in the field of neurological diagnostics has the potential to significantly impact patient care and diagnosis. His contributions through his patent and research continue to pave the way for advancements in understanding neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile